The Fort Worth Press - Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

USD -
AED 3.672501
AFN 66.495457
ALL 80.629676
AMD 365.091035
AOA 917.000132
ARS 1491.937897
AUD 1.417435
AWG 1.80125
AZN 1.700356
BAM 1.691649
BBD 2.00813
BDT 123.418242
BHD 0.375989
BIF 2985.079791
BMD 1
BND 1.277602
BOB 11.849673
BRL 5.083303
BSD 0.997016
BTN 94.875232
BWP 13.457596
BYN 2.968819
BYR 19600
BZD 2.00519
CAD 1.39515
CDF 2262.487483
CHF 0.80949
CLF 0.023206
CLP 913.315746
CNY 6.747602
CNH 6.743285
COP 3142.844787
CRC 453.228387
CUC 1
CUP 26.5
CVE 95.372573
CZK 20.982098
DJF 177.546166
DKK 6.467982
DOP 58.20179
DZD 132.308956
EGP 49.555853
ERN 15
ETB 160.923669
EUR 0.86495
FJD 2.20855
FKP 0.74148
GBP 0.742583
GEL 2.610266
GGP 0.74148
GHS 11.700039
GIP 0.74148
GMD 73.510995
GNF 8756.649224
GTQ 7.607144
GYD 208.588851
HKD 7.842299
HNL 26.723176
HRK 6.518802
HTG 130.363707
HUF 314.060243
IDR 17801
ILS 2.99985
IMP 0.74148
INR 95.210501
IQD 1306.058902
IRR 1375550.000156
ISK 123.339642
JEP 0.74148
JMD 158.335856
JOD 0.709022
JPY 157.806026
KES 129.014401
KGS 87.450366
KHR 4049.647537
KMF 425.999772
KRW 1407.860324
KWD 0.30866
KYD 0.830861
KZT 467.275008
LAK 22510.919863
LBP 89282.792025
LKR 334.420274
LRD 179.959348
LSL 16.197552
LTL 2.95274
LVL 0.60489
LYD 6.341738
MAD 9.29222
MDL 17.337716
MGA 4254.638239
MKD 53.219738
MMK 2099.549369
MNT 3595.852714
MOP 8.056654
MRU 40.080439
MUR 47.070197
MVR 15.450094
MWK 1728.841413
MXN 17.380226
MYR 4.090101
MZN 63.905023
NAD 16.197552
NGN 1364.859559
NIO 36.690741
NOK 9.51237
NPR 151.800372
NZD 1.701115
OMR 0.382693
PAB 0.997016
PEN 3.376465
PGK 4.406003
PHP 60.705001
PKR 276.796523
PLN 3.719205
PYG 5928.296501
QAR 3.644596
RON 4.536302
RSD 101.492021
RUB 81.598409
RWF 1466.072741
SAR 3.744756
SBD 8.065696
SCR 14.449077
SDG 600.501055
SEK 9.480801
SGD 1.269501
SLE 24.601635
SOS 569.822255
SRD 37.866504
STD 20697.981008
STN 21.191022
SVC 8.723782
SZL 16.194265
THB 33.050449
TJS 9.197509
TMT 3.51
TND 2.929032
TRY 47.697498
TTD 6.757774
TWD 32.250597
TZS 2639.622886
UAH 44.653894
UGX 3714.050945
UYU 40.133201
UZS 11924.058297
VES 755.762402
VND 26204.5
VUV 118.557141
WST 2.733716
XAF 567.363231
XAG 0.015731
XAU 0.00023
XCD 2.70255
XCG 1.796912
XDR 0.705618
XOF 567.363231
XPF 103.152705
YER 238.410014
ZAR 16.14632
ZMK 9001.199539
ZMW 18.818492
ZWL 321.999592
  • CMSC

    0.0240

    21.744

    +0.11%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • RIO

    1.4500

    101.1

    +1.43%

  • JRI

    0.1500

    12.81

    +1.17%

  • BCE

    -0.0200

    22.75

    -0.09%

  • BCC

    2.3400

    86.6

    +2.7%

  • BTI

    0.6000

    59.33

    +1.01%

  • GSK

    0.7900

    52.96

    +1.49%

  • BP

    -0.6000

    41.63

    -1.44%

  • NGG

    0.4700

    80.88

    +0.58%

  • VOD

    0.1900

    16.19

    +1.17%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • RELX

    0.0485

    35.52

    +0.14%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • AZN

    1.4100

    161.42

    +0.87%

Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)
Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

Beverly Hills spine surgeons complete three-level cervical disc replacement following recent FDA approval of motion-preserving technology

Text size:

BEVERLY HILLS, CA / ACCESS Newswire / April 8, 2026 / Todd H. Lanman, MD, and Joel S. Beckett, MD have performed the first post-approval case using the newly FDA-approved Synergy Disc®, marking an early clinical milestone for the motion-preserving cervical disc technology.

The procedure was performed on Monday at the Advanced Surgery Center of Beverly Hills five weeks after the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for the Synergy Disc® for single-level cervical disc replacement from C3-C7.

The patient, a 47-year-old man, presented with progressive neck pain, arm pain, and weakness in the setting of spinal cord compression and severe nerve root compression with associated bone spur formation. After failing conservative management, the patient was taken to surgery for a three-level cervical disc replacement to decompress the spinal cord, relieve nerve compression, and remove osteophytic pathology.

"This case reflects the continued evolution of motion-preserving spine surgery," said Dr. Lanman. "The ability to address complex pathology while preserving motion is central to how we think about treating cervical degenerative disease."

Dr. Beckett added, "With the recent FDA approval of the Synergy Disc, we now have access to a technology designed not only to preserve motion but also to support segmental alignment. That combination is important as we continue to refine surgical decision-making in cervical spine care."

The Synergy Disc® is a motion-preserving artificial cervical disc developed by Synergy Spine Solutions and engineered with a lordotic polyethylene core designed to maintain and restore physiologic alignment while allowing controlled motion. The Synergy Disc® is the only artificial cervical disc currently available that combines motion preservation with intentional alignment correction in a single device. The device recently demonstrated superiority to anterior cervical discectomy and fusion (ACDF) in a U.S. Investigational Device Exemption (IDE) clinical trial.

The patient is recovering well following surgery with early reduction in pain. Neurologic recovery will be assessed over time as healing progresses.

This first U.S. case represents an early step in the clinical adoption of the Synergy Disc®, with broader utilization expected as surgeons gain experience with the newly approved technology.

About Dr. Todd Lanman

Todd Lanman, MD has over three decades of experience as a spinal neurosurgeon and has spent the last 25 years practicing spine surgery in Beverly Hills. In addition to being a world-renowned spinal surgeon, Dr. Lanman has also had 11 spinal surgeries including spinal fusions and artificial disc replacements. Because of these experiences as surgeon and as patient, Dr. Lanman brings a unique perspective to his surgical practice.

About Dr. Joel S. Beckett

Joel S. Beckett, MD is a board-certified, dual fellowship-trained neurosurgeon specializing in complex spinal reconstruction, artificial disc replacement, and motion-preserving spine surgery. Educated at Yale, trained at UCLA, and refined at the Cleveland Clinic, Dr. Beckett combines rigorous academic training with advanced surgical technique. He is a former Director of Neurosurgical Spinal Oncology at UCLA and has authored more than 50 scientific publications, including work in AI-enhanced imaging and surgical planning.

About Lanman Spinal Neurosurgery

Lanman Spinal Neurosurgery is committed to improving patients' quality of life by relieving pain and restoring spinal motion. The Beverly Hills practice has been at the leading edge of spine health for the past quarter of a century. Lanman Spinal Neurosurgery has and continues to pioneer artificial disc replacement and fusion revision surgeries to help neck and back pain sufferers live their best lives.

About Beckett NeuroSpine

Beckett NeuroSpine is a specialty spine practice dedicated to the comprehensive treatment of spine disorders including complex and reconstructive spinal conditions. Led by dual fellowship-trained neurosurgeon Joel S. Beckett, MD, the practice emphasizes motion-preserving and minimally invasive techniques whenever appropriate while providing full spectrum spine care. Beckett NeuroSpine integrates advanced surgical planning, modern imaging technologies, and a patient-centered approach to deliver individualized treatment and restore function for patients with both routine and complex spinal pathology.

About Synergy Spine Solutions

The vision of Synergy Spine Solutions is to identify and commercialize innovative spine technologies that help surgeons improve their patients' quality of life and advance the standard of care. The company's flagship product, the Synergy Disc®, is the only device designed to restore both motion and alignment to the spine. For more information, visit www.synergyspinesolutions.com.

MEDIA CONTACT:
Brandi Kamenar
Brandi Kamenar Brand Management
BrandiKamenar.com
[email protected]
(310) 734-6180

SOURCE: Lanman Spinal Neurosurgery



View the original press release on ACCESS Newswire

J.P.Estrada--TFWP